ASP Isotopes Inc

NASDAQ:ASPIUnited States

ASP Isotopes Inc. is a pre-commercial stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100 and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

Contact Information

Headquarters

1101 Pennsylvania Avenue Nw, Suite 300WASHINGTON, DC, United States 20004

Phone

202-756-2245

Fax

302-636-5454

Executives

Chairman of the Board, Chief Executive Officer

Paul Mann

Interim Chief Financial Officer

Robert Ainscow

Chief Technology Officer, Director

Hendrik Strydom

Director

Rob Ryan

Independent Director

Michael Gorley